欧美日本一道本一区二区_亚洲免费影视_91手机在线看片_精品欧美成人高清在线观看_少妇作爱bbbb免费看_51久久夜色精品国产水果派解说

北京科興生物Sinovac Biotech???
北京科興生物制品有限公司是由中維科生物技術(shù)有限公司、北京北大未名生物工程集團(tuán)有限公司合資組建的生物高科技企業(yè)。公司于2001年在北京中關(guān)村高科技園區(qū)北大生物城注冊(cè)成立，注冊(cè)資本14121萬元人民幣。2003年9月北京科興在美國(guó)OTCBB上市，并于2004年底轉(zhuǎn)板美國(guó)證券交易所（AMEX），是中國(guó)第一家在美國(guó)上市的疫苗公司。
北京科興以“讓中國(guó)兒童使用國(guó)際品質(zhì)的疫苗，讓世界兒童使用中國(guó)生產(chǎn)的疫苗”為目標(biāo)，憑借先進(jìn)的生產(chǎn)工藝、國(guó)際化的質(zhì)量管理、安全有效的產(chǎn)品品質(zhì)、完善的售前、售后服務(wù)以及應(yīng)對(duì)新發(fā)傳染病的強(qiáng)有力的研發(fā)體系，將在生物醫(yī)藥領(lǐng)域中占據(jù)重要地位。
　2009年9月3日，由北京科興生物制品有限公司生產(chǎn)的甲型H1N1流感病毒裂解疫苗“盼爾來福．1”獲得國(guó)家食品藥品監(jiān)督管理局頒發(fā)的藥品批準(zhǔn)文號(hào)，批準(zhǔn)疫苗投入使用。全球首支獲得藥品批準(zhǔn)文號(hào)的甲型H1N1流感疫苗由此誕生。



Sinovac Biotech Ltd., a biopharmaceutical company, focuses on the research, development, manufacturing, and commercialization of vaccines that protect against human infectious diseases in China. Its portfolio of regulatory-approved products consists of vaccines against the hepatitis A, hepatitis B and influenza viruses. The company offers Healive, an inactivated hepatitis A vaccine; Bilive, a combination hepatitis A and B vaccine; Anflu, a split virus influenza vaccine; and Panflu, a vaccine against the H5N1 influenza virus. The company’s pipeline vaccine candidates in the pre-clinical and clinical development phases include human vaccines for Enterovirus 71, Japanese encephalitis virus, and rabies; a vaccine for the SARS virus, which completed Phase I clinical trial; animal rabies vaccine; and a split viron vaccine for the H5N1 influenza virus, which completed Phase II clinical trial. It markets and sells its vaccine products primarily through various provincial and municipal centers for disease control and prevention. Sinovac Biotech Ltd. was founded in 1999 and is headquartered in Beijing, the People’s Republic of China.